Biodegradable microparticles as a two-drug controlled release formulation: A potential treatment of inflammatory bowel disease

Journal of Controlled Release

Volumn 69, Issue 3, 2000, Pages 445-454

  Lamprecht, Alf ^a   Rodero Torres, Helena ^a   Schäfer, Ulrich ^a   Lehr, Claus Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Betamethasone; Inflammatory bowel disease; Microparticles; Solvent evaporation method; Sulfasalazine

Indexed keywords

BETAMETHASONE; POLYCAPROLACTONE; POLYESTER; POLYGLACTIN; POLYLACTIC ACID; SALAZOSULFAPYRIDINE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; ENTERITIS; EVAPORATION; MICROENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL;

BETAMETHASONE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; HUMANS; INFLAMMATORY BOWEL DISEASES; SOLUBILITY; SULFASALAZINE;

EID: 0034602598     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00331-X     Document Type: Article

References (24)

1. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment
2. National Cooperative Crohn's Disease Study: results of drug treatment
3. Gastrointestinal transit of small tablets in patients with ulcerative colitis
4. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis
5. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy
6. An experiment to determine the active therapeutic moiety of sulphasalazine
7. Side effects of salicylazosulfapyridine therapy
8. National Cooperative Crohn's Disease Study: adverse reactions to study drugs
9. Pharmacokinetics of betamethasone in healthy adults after intravenous administration
10. Polylactide microparticles prepared by double emulsion/evaporation technique. I. Effect of primary emulsion stability
11. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment
12. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres
13. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres
14. The preparation and evaluation of poly(ε-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug
15. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches
16. Poly(ε-caprolactone) and its copolymers
17. Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres
18. Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique
19. Effect of the emulsion stability on the morphology and porosity of semicrystalline poly-L-lactide microparticles prepared by w/o/w double emulsion-evaporation
20. Determination of the physical state of drug in microcapsule and microsphere formulations
21. Solvent selection in the preparation of poly(DL-lactide) microspheres prepared by the solvent evaporation method
22. Protein release from poly(ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study
23. Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems
24. Albumin release from bioerodable hydrogels based on semi-interpenetrating polymer networks composed of poly(ε-caprolactone) and poly(ethylene glycol) macromer